Human immunodeficiency virus (HIV) is one of the viruses that has co-evolved within human populations for a considerable time. With the evolution of new drug-resistant HIV strains, the necessity to discover novel drugs has become an issue of great concern, especially those that have increased binding affinities and inhibitory activity towards RT enzymes. This study used an in silico approach to identify potential HIV-RT inhibitory candidates from Origanum vulgare (oregano). An initial in silico screening of approximately 820 compounds was conducted, and based on molecular docking-derived binding energy scores, four compounds (IMPHY000687, IMPHY007084, IMPHY004619, and IMPHY012021), with docking scores of −9.42, −9.32, −9.24, and −9.23 kcal/mol, respectively, were selected as the top-ranked phytocompounds and were subsequently validated using multiple computational approaches. These compounds were geometrically optimized using quantum-chemical calculations, and detailed interaction analyses were performed using a redocking procedure. Reproducibility of the dynamic behavior was evaluated by carrying out independent replica molecular dynamics simulations for 300 ns each for all complexes. The ligand-dependent conformational dynamics were identified using RMSD and RMSF analyses, along with variations in positional changes during simulation times. PCA and FEL analyses helped in identifying the conformations sampled by the system under study. In addition, QM/MM calculations provided complementary information on the electronic characteristics of the individual protein–ligand systems. Machine learning-based quantitative structure–activity relationship (QSAR) prediction of experimentally validated HIV-RT inhibitors was applied to predict inhibitory potency, yielding predicted pIC50 values for the selected phytochemicals compared with the reference molecule. All in all, comprehensive computational analyses have ranked these phytochemicals as HIV-RT inhibitors that need further experimental verification.
Purpose Exposure to fluoride has increased significantly over the past decades. High incidence of fluorosis was reported in different parts of the kingdom indicating excessive intake. Excessive dietary fluoride produced anaemia and eosinophilia. We aimed to estimate fluoride intake in healthy adults, and investigate relationship between excessive consumption, and changes in blood cells indices. Methods 85 adults aged 20–50 years were recruited. Subjects were examined clinically for suitability, and dentally for fluorosis. Weight and height were measured to calculate body mass index. Demographic information and dietary intake were recorded face to face using structured, validated questionnaires. Fasting blood samples were collected for haematological evaluation. Fluoride was estimated in collected first morning urine, water samples, and various beverages. Fluoride intakes from food, water, and beverages were used to calculate the daily intake, which was used to divide subjects into high (HI) and low or optimal intake (LI) subgroups. Means of different estimated parameters of the two subgroups were compared statistically. Results Fluorosis was detected in 15 subjects. Urinary fluoride correlated significantly with fluoride intake (r = 0.54, P = 3 × 10− 4). Higher than adequate intake was found in 57 subjects. HI subgroup had significantly lower mean WBC, RBC counts, Hgb, MCV, MCH and MCHC (P < 0.03 at least), and an increased incidence of anaemia but higher mean eosinophils (P = 0.021), with 51% of subjects showing eosinophilia. Conclusion Excessive consumption of fluoride was observed among study participants, and was associated with increased incidence of anaemia and alterations in the blood cells indices.
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is characterized by aggressive tumour biology and is routinely treated with HER2-tar